Chairman/CEO: Dr. Guojun PanDr. Pan obtained his bachelor’s degree from Shandong University in 2001, and Master’s degree from Nanjing University in 2004 under the guidance of Professor Hongwen Hu, who is a member of the Chinese Academy of Science. In August 2008, he pursued his Ph.D. at Colorado State University, in the group of Professor Robert M. Williams. During his Ph.D. study, Dr. Pan independently completed total syntheses of four Lycoposerramine alkaloids. After graduation, he continued his research work in the group of Professor Ryan A. Shenvi at the Scripps Research Institute (La Jolla, CA), and then in the group of Professor Liming Zhang at The University of California, Santa Barbara. In March 2014, he joined Pharmablock Sciences (Nanjing), Inc. as a director, focusing on the synthesis of catalog compounds. In March 2017, Dr. Pan founded Nanjing Syntitan Pharmaceutical Co., Ltd., and worked as the chairman and CEO for SynTitan Pharma since then.